‘I’m going to keep pushing.’ Anthony Fauci tries to make the White House listen to facts of the pandemic https://www.sciencemag.org/news/2020/03/i-m-going-keep-pushing-anthony-fauci-tries-make-white-house-listen-facts-pandemic NIH’s axing of bat coronavirus…
Comments closedCategory: Science
The latest stories covering the outbreak from me and my colleagues at Science. Here’s the site: www.sciencemag.org/tags/coronavirus
Comments closed
The United States government routinely sues pharmaceutical companies for making false claims, bilking Medicare, illegal kickbacks, and sloppy manufacturing practices. But on 6 November, the…
Comments closed
An experimental dengue vaccine has shown promising early results in a large, multicountry trial, but critical questions remain about its effectiveness and safety. Still unclear,…
Comments closed
A 66% price slash of a little used but powerful drug that prevents tuberculosis (TB) could help stave off the deadly lung disease in millions…
Comments closed
By Jon Cohen, Jocelyn Kaiser Two major U.S. biomedical research funders plan to each put at least $100 million over 4 years toward bringing cutting-edge, gene-based treatments…
Comments closed
“Yevgenievna” and her husband in their apartment. She has been deaf since birth and her husband has limited hearing. She is considering allowing an experiment by Rebrikov to edit gene’s in her offspring’s embryo that may help avoid hearing loss. Credit: Sergey Ponomarev
This story was supported by the Pulitzer Center. On a lightly snowing Sunday evening, a potential participant in Denis Rebrikov’s controversial plans to create gene-edited babies meets…
Comments closed
Geneticist Denis Rebrikov in his lab. Credit: Sergey Ponomarev
This story was supported by the Pulitzer Center. Earlier this month, Denis Rebrikov went to an old mansion in Moscow that now houses the Russian…
Comments closed
CRISPR, an extraordinarily powerful genome-editing tool invented in 2012, can still be clumsy. It sometimes changes genes it shouldn’t, and it edits by hacking through…
Comments closed